Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bepotastine besilate ophthalmic solution reduces nasal symptoms in the Conjunctival Allergen Challenge (CAC) clinical model

Bepotastine besilate ophthalmic solution reduces nasal symptoms in the Conjunctival Allergen Challenge (CAC) clinical model. Western Society of Allergy, Asthma, and Immunology Meeting. 2009.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.